logo ct-atlantic








CT Atlantic AG is an emerging biotech company focused on the identification and development of human-derived monoclonal antibodies – HD-MABs™ as novel therapeutics for the treatment of cancer. CT Atlantic is a spin-off of the University of Zurich (Zurich, Switzerland) and the Ludwig Institute of Cancer Research (Zurich, Switzerland and New York, USA) and is based in Zurich-Schlieren, Switzerland.

Joining the CT Atlantic team
We know that our success is based on the success of our employees. We seek excellent employees, who share our commitment to developing novel immunotherapies to enhance patients' quality of life. We offer the chance to work in a multinational and highly dedicated team.

We are always looking for qualified candidates to enhance our team. We encourage you to send your curriculum vitae to info@ct-atlantic.com or to apply to any of the open positions matching your skills and experiences.

Contribute to our company and help make a difference!

Open positions:
Currently there are no open positions.